title: Methotrexate as a steroid-sparing agent in Cogan's syndrome: comment on the concise communication by Richardson.
authors.forename: J
authors.initials: J
authors.lastname: Pouchot
authors.forename: P
authors.initials: P
authors.lastname: Vinceneux
authors.forename: D
authors.initials: D
authors.lastname: Bouccara
authors.forename: O
authors.initials: O
authors.lastname: Sterkers
authors.forename: B
authors.initials: B
authors.lastname: Bodelet
mesh_terms: D000305:Adrenal Cortex Hormones / Q000008:administration & dosage* / Q000627:therapeutic use; D000328:Adult; D005260:Female; D006319:Hearing Loss, Sensorineural / Q000188:drug therapy*; D006801:Humans; D007634:Keratitis / Q000188:drug therapy*; D008727:Methotrexate / Q000627:therapeutic use*; D013577:Syndrome
chemical_list: D000305:Adrenal Cortex Hormones; D008727:Methotrexate